
Faculty, Staff and Student Publications
Publication Date
12-1-2023
Journal
Life Metabolism
Abstract
The lack of a reliable and specific marker for ferroptosis has hindered the advancement of treatments related to this cell death mechanism toward clinical application. A recent study published in Molecular Cell has identified hyperoxidized peroxiredoxin 3 (PRDX3) as a promising marker for ferroptosis, opening up new avenues for monitoring and targeting ferroptosis in disease treatment.
Keywords
Ferroptosis, biomarker, PRDX3, hyperoxidation, lipid peroxidation
DOI
10.1093/lifemeta/load042
PMID
38179338
PMCID
PMC10766428
PubMedCentral® Posted Date
November 2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Included in
Bioinformatics Commons, Biology Commons, Biomedical Informatics Commons, Medical Sciences Commons, Oncology Commons
Comments
NIHMSID: NIHMS1948572